Cryptococcal Antigen Lateral Flow Assay Test Market
The cryptococcal antigen lateral flow assay is a type of an immunochromotography test system, used to identify the capsular polysaccharide antigens of cryptococcus species present in serum and Cerebrospinal Fluid (CSF). The combinational use of immunoassay and chromatography has made revolutionary changes in the point of care diagnosis of cryptococcal fungi. The patient are allowing to monitor the presence of fungal infection through one strip of lateral flow assay test. These test are gaining popularity across major developed countries of North America and Europe, owing to their simple operating procedure as compared to other assay techniques. Moreover, the high accuracy and sensitivity with least lead time to produce outcome are providing opportunities for early stage development products.
The cryptococcal antigen lateral flow assay is a type of an immunochromotography test system, used to identify the capsular polysaccharide antigens of cryptococcus species present in serum and Cerebrospinal Fluid (CSF). The combinational use of immunoassay and chromatography has made revolutionary changes in the point of care diagnosis of cryptococcal fungi. The patient are allowing to monitor the presence of fungal infection through one strip of lateral flow assay test. These test are gaining popularity across major developed countries of North America and Europe, owing to their simple operating procedure as compared to other assay techniques. Moreover, the high accuracy and sensitivity with least lead time to produce outcome are providing opportunities for early stage development products.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Report Description<br />
The cryptococcal antigen lateral flow assay is a type of an immunochromotography test<br />
system, used to identify the capsular polysaccharide antigens of cryptococcus species<br />
present in serum and Cerebrospinal Fluid (CSF). The combinational use of immunoassay<br />
and chromatography has made revolutionary changes in the point of care diagnosis of<br />
cryptococcal fungi. The patient are allowing to monitor the presence of fungal infection<br />
through one strip of lateral flow assay test. These test are gaining popularity across major<br />
developed countries of North America and Europe, owing to their simple operating<br />
procedure as compared to other assay techniques. Moreover, the high accuracy and<br />
sensitivity with least lead time to produce outcome are providing opportunities for early<br />
stage development products.<br />
<strong>Cryptococcal</strong> <strong>Antigen</strong> <strong>Lateral</strong> <strong>Flow</strong> <strong>Assay</strong> <strong>Test</strong> <strong>Market</strong>: Drivers and Restraints<br />
Increasing incidence of cryptococcal infection, long waiting time to get test results,<br />
limited efficacy of substitute techniques would collective drive the growth of<br />
cryptococcal antigen lateral flow assay test market. Moreover, the active initiative from<br />
the government in Africa countries would provide boost to the market growth. However,<br />
limited awareness for cryptococcal antigen lateral flow assay test, and lack of skill work<br />
force would limit the adoption of cryptococcal antigen lateral flow assay test.<br />
Request free sample Report:<br />
http://www.futuremarketinsights.com/reports/sample/rep-gb-1227
Change language